The critically ill patient is capable of presenting a multiple organ dysfunction syndrome (MODS) caused by different diseases, which can be infectious (sepsis, septic shock) as well as non-infectious (pancreatitis, large surgeries, traumatic injuries, burn patients and brain injuries), this syndrome is characterized by global hemodynamic and organ perfusion alterations accompanied by an uncontrolled and marked inflammatory response unresponsive to pharmacological treatment due to which extracorporeal organ support can be a viable option. Acute renal lesion can occur in up to 60% of patients receiving intensive care, and close to 10% - 20% require renal replacement therapy (RRT) globally this can be provided as peritoneal dialysis (PD) or intermittent hemodialysis (IHD), continuous renal replacement therapy (CRRT), hybrid therapies known as sustained slow efficiency dialysis (SLED), which combines the benefits IHD and CRRT, slow continuous ultrafiltration (SCUF). Extracorporeal membrane oxygenation (ECMO) and extracorporeal elimination of CO 2 , have been used more frequently lately, these are temporal artificial support used for respiratory and/or cardiac insufficiency that is refractory to conventional treatment. Acute liver failure in adults has a mortality rate close to 50% furthermore one-third of patients hospitalized for cirrhosis are likely to progress to acute liver failure which will drastically increase its mortality. Based on concepts of albumin dialysis, one of its most known is the following: Molecular Adsorbent Recirculating System (MARS), Fractionated Plasma Separation and Absorption—FPSA (Prometheus ® ) and also, hemoperfusion with different cartridges used in different extracorporeal therapies, used in liver failure, rhabdomyolysis, cytokine release syndrome and more in the context of the pandemic covid19. The objective of this review is to know the different extracorporeal therapies and the therapeutic utility in critical patients.
Knaus, W.A., Draper, E.A., Wagner, D.P., et al. (1985) APACHE II: A Severity of Disease Classification System. Critical Care Medicine, 13, 818-829. https://doi.org/10.1097/00003246-198510000-00009
Seymour, C.W., Liu, V.X., Iwashyna, T.J., et al. (2016) Evaluación de los criterios clínicos para la sepsis: Para las definiciones del tercer consenso internacional para la sepsis y el shock séptico (Sepsis-3). JAMA, 315, 762. https://doi.org/10.1001/jama.2016.0288
Ziesmann, M.T. and Marshall, J.C. (2018) Multiple Organ Dysfunction: The Defining Syndrome of Sepsis. Surgical Infections, 19, 184-190. https://doi.org/10.1089/sur.2017.298
Ronco, C. (2006) Recent Evolution of Renal Replacement Therapy in the Critically Ill Patient. Critical Care, 10, 123. https://doi.org/10.1186/cc4843
Barie, P.S. and Hydo, L.J. (2000) Epidemiology of Multiple Organ Dysfunction Syndrome in Critical Surgical Illness. Surgical Infections, 1, 173-185. https://doi.org/10.1089/109629600750018105
Boomer, J.S., To, K., Chang, K.C., et al. (2011) Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure. JAMA, 306, 2594-2605. https://doi.org/10.1001/jama.2011.1829
De Backer, D., Orbegozo Cortes, D., Donadello, K. and Vincent, J.L. (2014) Pathophysiology of Microcirculatory Dysfunction and the Pathogenesis of Septic Shock. Virulence, 5, 73-79. https://doi.org/10.4161/viru.26482
Mongardon, N., Dyson, A. and Singer, M. (2009) Is MOF an Outcome Parameter or a Transient, Adaptive State in Critical Illness? Current Opinion in Critical Care, 15, 431-436. https://doi.org/10.1097/MCC.0b013e3283307a3b
Sakr, Y., Dubois, M.J., De Backer, D., Creteur, J. and Vincent, J.L. (2004) Persistent Microcirculatory Alterations Are Associated with Organ Failure and Death in Patients with Septic Shock. Critical Care Medicine, 32, 1825-1831. https://doi.org/10.1097/01.CCM.0000138558.16257.3F
De Backer, D., Ospina-Tascon, G., Salgado, D., Favory, R., Creteur, J. and Vincent, J.L. (2010) Monitoring the Microcirculation in the Critically Ill Patient: Current Methods and Future Approaches. Intensive Care Medicine, 36, 1813-1825. https://doi.org/10.1007/s00134-010-2005-3
Ospina-Tascon, G., Neves, A.P., Occhipinti, G., Donadello, K., Buchele, G., Simion, D., Chierego, M., Oliveira Silva, T., Fonseca, A., Vincent, J.L., et al. (2010) Effects of Fluids on Microvascular Perfusion in Patients with Severe Sepsis. Intensive Care Medicine, 36, 949-955. https://doi.org/10.1007/s00134-010-1843-3
ARDS (Acute Respiratory Distress Syndrome)
AKI (Acute Kidney Injury)
Jacobs, M.C., Haak, B.W., Hugenholtz, F. and Wiersinga, W.J. (2017) Gut Microbiota and Host Defense in Critical Illness. Current Opinion in Critical Care, 23, 257-263. https://doi.org/10.1097/MCC.0000000000000424
Uchino, S., Kellum, J.A., Bellomo, R., Doig, G.S., Morimatsu, H., Morgera, S., Schetz, M., Tan, I., Bouman, C., Macedo, E., Gibney, N., Tolwani, A. and Ronco, C. (2005) Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute Renal Failure in Critically Ill Patients: A Multinational, Multicenter Study. JAMA, 294, 813-818. https://doi.org/10.1001/jama.294.7.813
Tetta, C., Cavaillon, J.M., Schulze, M., Ronco, C., Ghezzi, P.M., Camussi, G., Serra, A.M., Curti, F. and Lonnemann, G. (1998) Removal of Cytokines and Activated Complement Components in an Experimental Model of Continuous Plasma Filtration Coupled with Sorbent Adsorption. Nephrology Dialysis Transplantation, 13, 1458-1464. https://doi.org/10.1093/ndt/13.6.1458
Gatward, J.J., Gibbon, G.J., Wrathall, G. and Padkin, A. (2008) Renal Replacement Therapy for Acute Renal Failure: A Survey of Practice in Adult Intensive Care Units in the United Kingdom. Anaesthesia, 63, 959-966. https://doi.org/10.1111/j.1365-2044.2008.05514.x
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International, 2, 1-138.
Zhao, Y.Y. and Chen, Y.F. (2020) Effect of Renal Replacement Therapy Modalities on Renal Recovery and Mortality for Acute Kidney Injury: A PRISMA-Compliant Systematic Review and Meta-Analysis. Seminars in Dialysis, 33, 127-132.
Martin, G.S., Mannino, D.M., Eaton, S., et al. (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. The New England Journal of Medicine, 348, 1546-1554. https://doi.org/10.1056/NEJMoa022139
Kellum, J.A., Kong, L., Fink, M.P., Weissfeld, L.A., Yealy, D.M., Pinsky, M.R., et al. (2007) Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (Genims) Study. Archives of Internal Medicine, 167, 1655-1663. https://doi.org/10.1001/archinte.167.15.1655
Weighardt, H., Heidecke, C.D., Emmanuilidis, K., et al. (2000) Sepsis after Major Visceral Surgery Is Associated with Sustained and Interferon-Gamma-Resistant Defects of Monocyte Cytokine Production. Surgery, 127, 309-315. https://doi.org/10.1067/msy.2000.104118
Donati, A., Domizi, R., Damiani, E., Adrario, E., Pelaia, P. and Ince, C. (2013) From Macrohemodynamic to the Microcirculation. Critical Care Research and Practice, 2013, Article ID: 892710. https://doi.org/10.1155/2013/892710
Marechal, X., Favory, R., Joulin, O., Montaigne, D., Hassoun, S., Decoster, B., Zerimech, F. and Neviere, R. (2008) Endothelial Glycocalyx Damage during Endotoxemia Coincides with Microcirculatory Dysfunction and Vascular Oxidative Stress. Shock, 29, 572-576. https://doi.org/10.1097/SHK.0b013e318157e926
Neri, M., Villa, G., Garzotto, F., et al. (2016) Nomenclature for Renal Replacement Therapy in Acute Kidney Injury: Basic Principles. Critical Care, 20, Article No. 318.
Cruz, D.N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., et al. (2009) Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial. JAMA, 301, 2445-2452. https://doi.org/10.1001/jama.2009.856
Kellum, J.A., Song, M. and Venkataraman, R. (2004) Hemoadsorption Removes Tumor Necrosis Factor, Interleukin-6, and Interleukin-10, Reduces Nuclear Factor-Kappab DNA Binding, and Improves Short-Term Survival in Lethal Endotoxemia. Critical Care Medicine, 32, 801-805. https://doi.org/10.1097/01.CCM.0000114997.39857.69
Peng, Z.Y., Carter, M.J. and Kellum, J.A. (2008) Effects of Hemoadsorption on Cytokine Removal and Short-Term Survival in Septic Rats. Critical Care Medicine, 36, 1573-1577. https://doi.org/10.1097/CCM.0b013e318170b9a7
Zuccari, S., et al. (2020) Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb. Blood Purification, 49, 107-113. https://doi.org/10.1159/000502540
Ruiz, D.D., Miguel, F.S.F., de Molina, G.F.J., Ubeda-Iglesias, A., Pérez, N.A. and Forés, R.J. (2017) Plasmapheresis and Other Extracorporeal Filtration Techniques in Critical Patients. Medicina Intensiva, 41, 174-187. https://doi.org/10.1016/j.medin.2016.10.005
Nakanishi, T., Suzuki, N., Kuragano, T., Nagasawa, Y. and Hasuike, Y. (2014) Current topics in Therapeutic Plasmapheresis. Clinical and Experimental Nephrology, 18, 41-49. https://doi.org/10.1007/s10157-013-0838-0
Williams, M.E. and Balogun, R.A. (2014) Principles of Separation: Indications and Therapeutic Targets for Plasma Exchange. Clinical Journal of the American Society of Nephrology, 9, 181-190. https://doi.org/10.2215/CJN.04680513
Bernal, W. and Wendon, J. (2013) Acute Liver Failure. The New England Journal of Medicine, 369, 2525-2534. https://doi.org/10.1056/NEJMra1208937
Stravitz, R.T., Bowling, R., Bradford, R.L., et al. (2013) Role of Procoagulant Microparticles in Mediating Complications and Outcome of Acuteliver Injury/Acute Liver Failure. Hepatology, 58, 304-313. https://doi.org/10.1002/hep.26307
Patel, P., et al. (2011) Use of Therapeutic Plasma Exchange as a Rescue Therapy in 2009 pH1N1 Influenza A—An Associated Respiratory Failure and Hemodynamic Shock. Pediatric Critical Care Medicine, 12, e87-e89.
Dellinger, R.P., Bagshaw, S.M., Antonelli, M., et al. (2018) Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients with Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial. JAMA, 320, 1455-1463. https://doi.org/10.1001/jama.2018.14618
Sloan, S.R., Andrzejewski Jr., C., Aqui, N.A., Kiss, J.E., Krause, P.J. and Park, Y.A. (2015) Role of the Rapeuticapheresis in Infectious and Inflammatory Diseases: Current Knowledge and Unanswered Questions. Journal of Clinical Apheresis, 30, 259-264. https://doi.org/10.1002/jca.21370
Faqihi, F., et al. (2020) Therapeutic Plasma Exchange in Adult Critically Ill Patients with Life-Threatening SARS-CoV-2 Disease: A Pilot Study. Journal of Critical Care, 60, 328-333. https://doi.org/10.1016/j.jcrc.2020.07.001
Knaup, H., Stahl, K., Schmidt, B.M.W., et al. (2018) Early Therapeutic Plasma Exchange in Septic Shock: A Prospective Open-Label Nonrandomized Pilot Study Focusing on Safety, Hemodynamics, Vascular Barrier Function, and Biologic Markers. Critical Care, 22, 285. https://doi.org/10.1186/s13054-018-2220-9
Naghavi, M., Abajobir, A.A., Abbafati, C., Abbas, K.M., Abd-Allah, F., Abera, S.F., et al. (2017) Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1151-1210. https://doi.org/10.1016/S0140-6736(17)32152-9
Moreau, R. and Arroyo, V. (2015) Acute-on-Chronic Liver Failure: A New Clinical Entity. Clinical Gastroenterology and Hepatology, 13, 836-841. https://doi.org/10.1016/j.cgh.2014.02.027
Grodzicki, M., Kotulski, M., Leonowicz, D., Zieniewicz, K. and Krawczyk, M. (2009) Results of Treatment of Acute Liver Failure Patients with Use of the Prometheus FPSA System. Transplantation Proceedings, 41, 3079-3081. https://doi.org/10.1016/j.transproceed.2009.08.024
Nakae, H., Eguchi, Y., Saotome, T., Yoshioka, T., Yoshimura, N., Kishi, Y., et al. (2010) Multicenter Study of Plasma Diafiltration in Patients with Acute Liver Failure. Therapeutic Apheresis and Dialysis, 14, 444-450. https://doi.org/10.1111/j.1744-9987.2010.00864.x
ELSO (2017) Guidelines for Cardiopulmonary Extracorporeal Life Support Extracorporeal Life Support Organization, Version 1.4.
Angus, D.C. and van der Poll, T. (2013) Severe Sepsis and Septic Shock. The New England Journal of Medicine, 369, 840-851. https://doi.org/10.1056/NEJMra1208623
Sato, R. and Nasu, M. (2015) A Review of Sepsis-Induced Cardiomyopathy. Journal of Intensive Care, 3, 48. https://doi.org/10.1186/s40560-015-0112-5
Barbaro, R.P., Odetola, F.O., Kidwell, K.M., et al. (2015) Association of Hospital-Level Volume of Extracorporeal Membrane Oxygenation Cases and Mortality. Analysis of the Extracorporeal Life Support Organization Registry. American Journal of Respiratory and Critical Care Medicine, 191, 894-901. https://doi.org/10.1164/rccm.201409-1634OC
Mebazaa, A., Combes, A., van Diepen, S., et al. (2018) Management of Cardiogenic Shock Complicating Myocardial Infarction. Intensive Care Medicine, 44, 760-773. https://doi.org/10.1007/s00134-018-5214-9
Guglin, A., Zucker, M.J., Bazan, V.M., et al. (2019) Venoarterial ECMO for Adults JACC Scientific Expert Panel. JACC, 73, 698-716.
Muller, G., Flecher, E., Lebreton, G., et al. (2016) The ENCOURAGE Mortality Risk Score and Analysis of Long-Term Outcomes after VA-ECMO for Acute Myocardial Infarction with Cardiogenic Shock. Intensive Care Medicine, 42, 370-378. https://doi.org/10.1007/s00134-016-4223-9
Russo, J.J., Aleksova, N., Pitcher, I., et al. (2019) Left Ventricular Unloading during Extracorporeal Membrane Oxygenation in Patients with Cardiogenic Shock. Journal of the American College of Cardiology, 73, 654-662. https://doi.org/10.1016/j.jacc.2018.10.085
Gattinoni, L., Pesenti, A., Mascheroni, D., Marcolin, R., Fumagalli, R., Rossi, F., et al. (1986) Low-Frequency Positive-Pressure Ventilation with Extracorporeal CO2 Removal in Severe Acute Respiratory Failure. JAMA, 256, 881-886. https://doi.org/10.1001/jama.256.7.881
López-Saubidet, I., Rodríguez, P.O., Maskin, P., Attie, S., Bonelli, I. and Valentini, R. (2011) Utilization of Extracorporeal Membrane Oxygenation in Late Stage of the Acute Respiratory Distress Syndrome. Medicina Intensiva, 35, 448-450. https://doi.org/10.1016/j.medin.2010.12.007
Repesse, X., Charron, C. and Vieillard-Baron, A. (2015) Acute Corpulmonale in ARDS: Rationale for Protecting the Right Ventricle. Chest, 147, 259-265. https://doi.org/10.1378/chest.14-0877
Terragni, P.P., Del Sorbo, L., Mascia, L., et al. (2009) Tidal Volume Lower than 6 ml/kg Enhances Lung Protection: Role of Extracorporeal Carbon Dioxide Removal. Anesthesiology, 111, 826-835. https://doi.org/10.1097/ALN.0b013e3181b764d2
Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J. and Pinsky, M.R. (2001) Epidemiology of Severe Sepsis in the United States: Analysis of Incidence, Outcome, and Associated Costs of Care. Critical Care Medicine, 29, 1303-1310. https://doi.org/10.1097/00003246-200107000-00002